JP3701000006
JP3701000006
JCR PHARMACEUTICAL CO
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 62/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±46.3% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.2x).
Beta (Market Relation)
0.18x
DefensiveVolatility (5Y p.a.)
46.3% p.a.
5-Year HorizonMax Drawdown (5Y)
-86.6%
5-Year HorizonSharpe Ratio
-0.67
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Volatility Expansion (3Y > 5Y) High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -18.2% |
| 3 Years | 48.9% | -70.3% | -0.57 | -25.2% |
| 5 Years | 46.3% | -86.6% | -0.67 | -28.7% |
| 10 Years | 43.5% | -89.5% | -0.1 | -1.9% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 High valuation risk: Avg P/E of 72.1 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (46.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -89.5% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
8 ISS Score: 8 / 10
Audit Risk
4 ISS Score: 4 / 10
Board Risk
7 ISS Score: 7 / 10
Short Ratio
-